"Parallel Track" CDC Daily UpdateImportant note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow



"Parallel Track"

New York Times (12/20/89), P. A26
Braff, Jeffrey


Abstract: A front-page New York Times story on clinical trials of DDI (Nov. 21) prematurely condemned to failure a new parallel-track testing procedure, writes Jeffrey Braff, executive director of the Gay Men's Health Crisis. It is too early to tell whether or not making the drug available to people outside of the trials as the trials progress will have an adverse affect on the studies and the collection of data, writes Braff. Despite the troubles of other trials, the National Institutes of Health has not had difficulty recruiting participants for DDI, notes Braff. The parallel track program, Braff says, may prove to be an effective way to gather data only available in clinical trials while simultaneously slowing disease progression for other outside the trials. Braff concludes that any program with the potential to save lives is entitled to an opportunity and should not be judged until the results are completely reported.


891220
AD892685


Copyright © 1989 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.